TNF-α-mediated stress-induced early pregnancy loss: A possible role of leukemia inhibitory factor

Chemical Immunology and Allergy

Volumn 89, Issue , 2006, Pages 62-71

  Torchinsky, A ^a   Markert, U R ^b   Toder, V ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 6; LIF PROTEIN, MOUSE;

BLASTOCYST; CELL DEATH; EMBRYO DEATH; HUMAN; IMMUNOSTIMULATION; IMPLANTATION; NONHUMAN; PATHOGENESIS; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STRESS; TROPHOBLAST; UPREGULATION; UTERUS; ANIMAL; FEMALE; FETUS DEATH; IMMUNOLOGY; MOUSE; PREGNANCY;

ANIMALS; BLASTOCYST; FEMALE; FETAL DEATH; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; MICE; PREGNANCY; SIGNAL TRANSDUCTION; STRESS; TUMOR NECROSIS FACTOR-ALPHA; UTERUS;

EID: 27244439545     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (44)

1. Wilson JG: Current status of teratology: General principles and mechanisms derived from animal studies; in Wilson JG, Fraser FC (eds): Handbook of Teratology: General Principles and Etiology. New York, Plenum Press, 1977, vol 1, pp 47-74.
2. Clark DA, Arck PC, Chaouat G: Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level. Am J Reprod Immunol 1999;41:5-22.
3. Toder V, Carp H, Fein A, Torchinsky A: The role of pro- and anti-apoptotic molecular interactions in embryonic maldevelopment. Am J Reprod Immunol 2002;48:235-244.
4. Chaouat G, Zourbas S, Ostojic S, Lappree-Delage G, Dubanchet S, Ledee N, Martal J: A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002;53:241-256.
5. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ: Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992;359:76-79.
6. Terranova PF, Hunter VJ, Roby KF, Hunt JS: Tumor necrosis factor-α in the female reproductive tract. Proc Soc Exp Biol Med 1995;209:325-342.
7. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G: Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996;184:1397-1411.
8. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ: Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997;94:8093-8098.
9. Toder V, Fein A, Carp H, Torchinsky A: TNF-alpha in pregnancy loss and embryo maldevelopment: A mediator of detrimental stimuli or a protector of the fetoplacental unit? J Assist Reprod Genet 2003;20:73-81.
10. Chaouat G, Menu E, Wegmann TG: Role of lymphokines of the CSF family and of TNF, gamma interferon and IL-2 in placental growth and fetal survival studied in two murine models of spontaneous resorptions; in Chaouat G, Mowbray JF (eds): Cellular and Molecular Biology of the Maternal-Fetal Relationship. Paris, INSERM/John Libbey Eurotext, 1991, pp 91-104.
11. Tangri S, Raghupathy R: Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol Reprod 1993;49:850-856.
12. Raghupathy R: Pregnancy: Success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol 2001;13:219-227.
13. Pampfer S, Wuu YD, Vanderheyden I, De Hertogh R: Expression of tumor necrosis factor-alpha (TNF alpha) receptors and selective effect of TNF alpha on the inner cell mass in mouse blastocysts. Endocrinology 1994;134:206-212.
14. Pampfer S, Vanderheyden I, McCracken JE, Vesela J, De Hertogh R: Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor-alpha in vitro. Development 1997;124:4827-4836.
15. Wuu YD, Pampfer S, Becquet P, Vanderheyden I, Lee KH, De Hertogh R: Tumor necrosis factor α decreases the viability of mouse bla stocysts in vitro and in vivo. Biol Reprod 1999;60:479-483.
16. Soto P, Natzke RP, Hansen PJ: Actions of tumor necrosis factor-alpha on oocyte maturation and embryonic development in cattle. Am J Reprod Immunol 2003;50:380-388.
17. Pampfer S, Cordi S, Cikos S, Picry B, Vanderheyden I, Hertogh RD: Activation of nuclear factor kappaB and induction of apoptosis by tumor necrosis factor-alpha in the mouse uterine epithelial WEG-1 cell line. Biol Reprod 2000;63:879-886.
18. Pampfer S: Dysregulation of the cytokine network in the uterus of the diabetic rat. Am J Reprod Immunol 2001;45:375-381.
19. Monzon-Bordonaba F, Vadillo-Ortega F, Feinberg RF: Modulation of trophoblast function by tumor necrosis factor-alpha: A role in pregnancy establishment and maintenance? Am J Obstet Gynecol 2002;187:1574-1580.
20. Gorivodsky M, Zemliak I, Orenstein H, Savion S, Fein A, Torchinsky A, Toder V: Tumor necrosis factor alpha mRNA and protein expression in the uteroplacental unit of mice with pregnancy loss. J Immunol 1998;160:4280-4288.
21. Gendron RL, Nestel FP, Lapp WS, Baines MG: Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumor necrosis factor-alpha. J Reprod Fertil 1990;90:395-402.
22. Arck PC, Meroli FS, Manuel J, Chaouat G, Clark DA: Stress-triggered abortion: Inhibition of protective suppression and promotion of tumor necrosis factor-α (TNF-α) release as a mechanism triggering resorptions in mice. Am J Reprod Immunol 1995;33:74-80.
23. Torchinsky A, Toder V, Carp H, Orenstein H, Fein A: In vivo evidence for the existence of a threshold for hyperglycemia-induced major fetal malformations: Relevance to the etiology of diabetic teratogenesis. Early Pregnancy 1997;3:27-33.
24. Fein A, Kostina E, Savion S, Orenstein H, Shepshelovich J, Ornoy A, Torchinsky A, Toder V: Expression of tumor necrosis factor-α in the uteroplacental unit of diabetic mice: Effect of maternal immunopotentiation. Am J Reprod Immunol 2001;46:161-168.
25. Ito K, Karasawa M, Kawano T, Akasaka T, Koseki H, Akutsu Y, Kondo E, Sekiya S, Sekikawa K, Harada M, Yamashita M, Nakayama T, Taniguchi M: Involvement of decidual Valpha14 NKT cells in abortion. Proc Natl Acad Sci USA 2000;97:740-744.
26. Torchinsky A, Gongadze M, Orenstein H, Savion S, Fein A, Toder V: TNF-alpha acts to prevent occurrence of malformed fetuses in diabetic mice. Diabetologia 2004;47:132-139.
27. Machado AF, Zimmerman EF, Hovland DN, Weiss R, Collins MD: Diabetic embryopathy in C57BL/6J mice. Altered fetal sex ratio and impact of the splotch allele. Diabetes 2001;50:1193-1199.
28. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F: Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003;374:1-20.
29. Ernst M, Jenkins BJ: Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet 2004;20:23-32.
30. Horvath CM: STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 2000;25:496-502.
31. Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander WS, Wicks IP, Tarlinton DM, Novak U, Heath JK, Dunn AR: Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001;194:189-203.
32. Corvinus FM, Fitzgerald JS, Friedrich K, Markert UR: Evidence for a correlation between trophoblast invasiveness and STAT3 activity. Am J Reprod Immunol 2003;50:316-321.
33. Cheng JG, Rodriguez CI, Stewart CL: Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: Towards a molecular understanding of 'the window of implantation'. Rev Endocr Metab Disord 2002;3:119-126.
34. Hamilton JA, Waring PM, Filonzi EL: Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha. J Immunol 1993;150:1496-1502.
35. Aloisi F, Rosa S, Testa U, Bonsi P, Russo G, Peschle C, Levi G: Regulation of leukemia inhibitory factor synthesis in cultured human astrocytes. J Immunol 1994;152:5022-5031.
36. Lorenzo JA, Jastrzebski SL, Kalinowski JF, Downie E, Korn JH: Tumor necrosis factor alpha stimulates production of leukemia inhibitory factor in human dermal fibroblast cultures. Clin Immunol Immunopathol 1994;70:260-265.
37. Laird SM, Tuckerman EM, Cork BA, Li TC: Expression of nuclear factor kappa B in human endometrium; role in the control of interleukin 6 and leukaemia inhibitory factor production. Mol Hum Reprod 2000;6:34-40.
38. Baud V, Karin M: Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001;11:372-377.
39. Torchinsky A, Toder V: To die or not to die: The function of the transcription factor NF-kappaB in embryos exposed to stress. Am J Reprod Immunol 2004;51:138-143.
40. Karin M, Cao Y, Greten FR, Li ZW: NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2002;2:301-310.
41. Makarov SS: NF-kappaB as a therapeutic target in chronic inflammation: Recent advances. Mol Med Today 2000;6:441-448.
42. Li X, Stark GR: NFkappaB-dependent signaling pathways. Exp Hematol 2002;30:285-296.
43. Fasshauer M, Klein J, Lossner U, Paschke R: Isoproterenol is a positive regulator of the suppressor of cytokine signaling-3 gene expression in 3T3-L1 adipocytes. J Endocrinol 2002;175:727-733.
44. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R: Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes. J Endocrinol 2004;181:129-138.